Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


In this issue


Home Eurosurveillance Edition  2016: Volume 21/ Issue 34 Article 5
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 21, Issue 34, 25 August 2016
News
Eurosurveillance editorial team: ESCAIDE ‘late-breaker’ abstract call opens 1 September 2016

+ Author affiliations


Citation style for this article: Eurosurveillance editorial team. ESCAIDE ‘late-breaker’ abstract call opens 1 September 2016. Euro Surveill. 2016;21(34):pii=. DOI: http://dx.doi.org/30322


The 2016 European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) will take place from 28 to 30 November 2016.

The later breaker call for abstracts will open on 1 September and may only be submitted online, through the ESCAIDE booking site.

Late breaker abstracts may be eligible for both oral and poster presentation at the Conference. To be eligible, the abstract must fulfil all the following criteria:

  • a) report on acute urgent public health problems OR b) contain novel, surprising findings; AND

  • report data or information that was unavailable before 11 May 2016 (the deadline for submission in the general call for abstracts for ESCAIDE), AND

  • have not been published before.

More information about the late breaker call is available here.

The programme and conference registration instructions are available on the ESCAIDE conference website. For further information, contact:




Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.